Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Windham Venture Partners

Investor type Venture Capital
Founders Adam Fine Roger Fine

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 48
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 28
Rounds per year 3.00
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 3
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical Device
  • Medical
  • Health Diagnostics
Summary

In 2006 was created Windham Venture Partners, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the New York.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Neotract, CVRx, Earlens Corporation Among the most successful fund investment fields, there are SaaS, Manufacturing.

The higher amount of exits for fund were in 2019. Opposing the other organizations, this Windham Venture Partners works on 19 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. The typical startup value when the investment from Windham Venture Partners is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Windham Venture Partners, startups are often financed by Versant Ventures, Split Rock Partners, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures HC, Vertex Ventures, Versant Ventures. In the next rounds fund is usually obtained by New Enterprise Associates, Vertex Ventures HC, Versant Ventures.

The current fund was established by Adam Fine, Roger Fine. We also calculated 3 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Windham Venture Partners:
Typical Co-investors
Windham Venture Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Windham Venture Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Belt Road Capital Management Cambodia, Phnom Penh
Bios Partners Fort Worth, Texas, United States
BioTex Finance Houston, Texas, United States
Blue Chip Capital -
Bright Technologies Fund Lugano, Switzerland, Ticino
Brooke Private Equity Advisors Boston, Massachusetts, United States
Galois Capital California, San Francisco, United States
High Peak Capital -
Japan-Israel Hi-Tech Ventures -
Medical Technologies Innovation Asia China, Hong Kong, Hong Kong Island
Myeloma Investment Fund Brookline, Massachusetts, United States
Native Angels Network Delhi, India, New Delhi
Stage 1 Ventures Massachusetts, United States, Waltham
Synergia Capital Partners Netherlands, Utrecht, Veenendaal
Tallwood Venture Capital California, Menlo Park, United States
Tech Wildcatters Dallas, Texas, United States
Vulcan Seattle, United States, Washington
Zhejiang Silicon Paradise Asset Management Group China, Hangzhou, Zhejiang
ZJ Innopark (Zhangjiang Hi-Tech Park) China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Upward Health

13 Sep 2022 Providence, Rhode Island, United States

Delfi Diagnostics

Biotechnology
Health Care
Health Diagnostics
$225M18 Jul 2022 Baltimore, Maryland, United States

Valera Health

Analytics
Health Care
Hospital
$15M04 Nov 2021 New York, New York, United States

Clever Care Health Plan Inc.

Health Care
Health Insurance
Insurance
$71M22 Sep 2021 California, United States

NeuSpera Medical

Biopharma
Health Care
Medical Device
$65M20 Jul 2021 San Jose, California, United States

Alto Neuroscience

Artificial Intelligence
Biopharma
Neuroscience
$32M03 May 2021 Los Altos, California, United States

Upward Health

02 Mar 2021 Providence, Rhode Island, United States

Personal Genome Diagnostics

Analytics
Bioinformatics
Biotechnology
Genetics
Health Diagnostics
Medical
$103M10 Feb 2021 Baltimore, Maryland, United States

Valera Health

Analytics
Health Care
Hospital
$3M03 Feb 2021 New York, New York, United States
News
Neuspera Medical Closes $65M Series C Equity Financing

– Neuspera Medical Inc. closed a $65m series C equity financing.
– The round was co-led by Vertex Ventures HC and Treo Ventures with participation from returning Series A and Series B investors Action Potential Venture Capital and Windham Venture Partners.
– The new funding will be used to conduct the SANS-UUI pivotal clinical study of its miniaturized implantable neuromodulation technology platform for use in subjects with Urinary Urgency Incontinence, a symptom of overactive bladder (OAB).

Upward Health Announces Significant Growth Equity Investment Led by Heritage Group

– Upward Health raised a significant equity financing led by Heritage Group, with participation from existing investors including Noro-Moseley Partners, the Blue Venture Fund and Windham Ventures.
– The company partners with health plans, taking on risk and guaranteeing outcomes in both cost and quality across their most complex and high-cost populations.
– The company pairs these members with care specialists who form trusted relationships and coordinate all aspects of the members’ care.
– Upward Health enables Facilitated Virtual Care™ visits with Upward Health providers and works to support and strengthen any existing member relationships with primary care physicians.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Windham Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: